English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/43162
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Comparison of alpha-1-acid glycoprotein isoforms from healthy and cancer patients by capillary IEF

AutorLacunza, Izaskun ; Kremmer, Tibor; Diez-Masa, Jose Carlos; Sanz Perucha, Jesús ; Frutos, Mercedes de
Palabras clavea-1-Acid glycoprotein
Tumor marker
Fecha de publicacióndic-2007
EditorJohn Wiley & Sons
CitaciónElectrophoresis 28 : 4447–4451 (2007)
Resumena-1-Acid glycoprotein (AGP) is a glycoprotein that presents different forms in the same in- dividual, depending on the amino acid sequence and/or on the carbohydrate distribution of each form. Changes in these two types of heterogeneities are related to pathophysiological states. The aim of this work is to study the possibility of comparing AGP samples in terms of their CIEF profiles, what would facilitate in a future to perform studies about the role of AGP as a disease marker. In the present study, the CIEF profiles of AGP samples purified from sera of healthy donors and of ovary cancer and lymphoma patients are qualitatively and quantitatively compared. To make possible the comparison of those electrophoretical profiles, reliable assignment of AGP peaks is necessary. A computer program developed in our laboratory is used to select the migration parameters that make possible an accurate assignment of AGP peaks. Percentages of correct assignment of AGP peaks using the migration time of each peak relative to the migration time of an internal standard close to 95% are achieved. After peak assignment, a different distribution of the area percentage of AGP forms is observed when comparing samples from diseased and healthy individuals, the most acidic AGP forms being present in a higher proportion in the samples from cancer patients. Although the number of samples studied is too low to get any clinical significance from these results, this work provides a way to study the role of AGP as a biomarker.
Versión del editorhttp://dx.doi.org/10.1002/elps.200600700
Aparece en las colecciones: (IQOG) Artículos
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro completo

Artículos relacionados:

NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.